Microbot Medical Boosts Manufacturing And Commercialization Capabilities For Its Robotic Surgical System
Portfolio Pulse from Happy Mohamed
Microbot Medical Inc. (NASDAQ:MBOT) has signed a manufacturing agreement with B.Y. Medimor Ltd. for its LIBERTY® Robotic Surgical System. The agreement covers the manufacturing of the system for its first human clinical trial and the initial systems expected to be marketed after regulatory requirements are met. Medimor provides full turnkey manufacturing for medical devices.
August 15, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Microbot Medical's new manufacturing agreement with B.Y. Medimor for its LIBERTY® Robotic Surgical System could accelerate the system's commercialization process.
The manufacturing agreement with B.Y. Medimor is a significant step for Microbot Medical as it could expedite the commercialization of its LIBERTY® Robotic Surgical System. This could potentially lead to increased revenues in the future, which is positive for the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100